Search Form

PERFORMANCE



The Hypothetical Growth of $10,000 chart reflects a hypothetical $10,000 investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted.



The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted, and numbers may reflect small variances due to rounding. Standardized performance and performance data current to the most recent month end may be obtained by clicking the "Returns" tab above.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.

Ex-Date Payable Date Record Date Total Distribution   Income ST Cap Gains LT Cap Gains Return on Capital

Past distributions are not indicative of future distributions.



The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted, and numbers may reflect small variances due to rounding. Standardized performance and performance data current to the most recent month end may be obtained by clicking the "Returns" tab above.

Holdings

as of 03-Mar-2015

Holding Weight (%) Sector Country Market Value Shares Price Exchange Currency Market Currency FX Rate Notional Value
holding-image

JNJ

JOHNSON & JOHNSON

6.78 Health Care United States $109,182,759 1,066,863 102.34 New York Stock Exchange Inc. USD USD 1.00 109,182,759.42
holding-image

NOVN

NOVARTIS AG

6.33 Health Care Switzerland $102,031,514 1,031,109 98.95 Six Swiss Exchange Ag USD CHF 0.96 102,031,513.98
holding-image

PFE

PFIZER INC

5.15 Health Care United States $82,998,536 2,401,578 34.56 New York Stock Exchange Inc. USD USD 1.00 82,998,535.68
holding-image

ROG

ROCHE HOLDING AG

4.50 Health Care Switzerland $72,539,472 267,852 270.82 Six Swiss Exchange Ag USD CHF 0.96 72,539,471.90
holding-image

MRK

MERCK & CO INC

3.94 Health Care United States $63,389,794 1,086,558 58.34 New York Stock Exchange Inc. USD USD 1.00 63,389,793.72
holding-image

GILD

GILEAD SCIENCES INC

3.67 Health Care United States $59,113,912 575,094 102.79 NASDAQ USD USD 1.00 59,113,912.26
holding-image

BAYN

BAYER AG

2.88 Health Care Germany $46,329,022 315,120 117.53 Xetra USD EUR 1.12 46,329,021.97
holding-image

AMGN

AMGEN INC

2.85 Health Care United States $45,977,802 289,971 158.56 NASDAQ USD USD 1.00 45,977,801.76
holding-image

GSK

GLAXOSMITHKLINE PLC

2.75 Health Care United Kingdom $44,302,630 1,858,299 10.09 London Stock Exchange USD GBP 1.54 44,302,630.50
holding-image

SAN

SANOFI SA

2.74 Health Care France $44,177,773 458,439 77.04 Nyse Euronext - Euronext Paris USD EUR 1.12 44,177,773.14
Ticker ISIN SEDOL Name Weight (%) Asset Class Sector Country Market Value Shares Price Exchange Currency Market Currency FX Rate Notional Value
Holdings are subject to change.

Exposure Breakdowns

as of 03-Mar-2015
  United States 65.15%
  Switzerland 11.27%
  United Kingdom 6.27%
  Germany 4.29%
  Japan 3.74%
  France 3.28%
  Denmark 2.42%
  Canada 1.73%
  Australia 1.21%
  Other 0.63%
Show all 10 countries
Geographic exposure relates principally to the domicile of the issuers of the securities held in the product, added together and then expressed as a percentage of the product’s total holdings. However, in some instances it can reflect the country where the issuer of the securities carries out much of their business.
as of 03-Mar-2015

% of Market Value

Pharma, Biotech & Life Sciences

75.00%

Health Care Equipment & Services

24.59%

Cash and/or Derivatives

0.41%

Allocations are subject to change.
How to buy iShares ETFs

KEY FACTS

Net Assets

as of 04-Mar-2015

$1,615,302,587
Inception Date Nov 13, 2001
Exchange NYSE Arca
Asset Class Equity
Benchmark Index S&P Global 1200 Healthcare Sector Index™
Index Ticker SGHNW

Shares Outstanding 15,150,000
Number of Holdings  

as of 02-Mar-2015

90
CUSIP 464287325
Closing Price  

as of 04-Mar-2015

106.63
20 Day Avg. Volume   27,879
Premium/Discount  

as of 04-Mar-2015

0.10%
Options Available No

FEES as of 31-Mar-2014

Expense Ratio  

0.48%

FEES as of 31-Dec-2014

Expense Ratio  

0.47%

PORTFOLIO CHARACTERISTICS

P/E Ratio  

as of 03-Mar-2015

25.86
P/B Ratio  

as of 03-Mar-2015

4.39

Equity Beta  

as of 30-Jan-2015

0.72
Standard Deviation (3y)  

as of 30-Jan-2015

9.64%

12m Trailing Yield  

as of 30-Jan-2015

1.34%
Distribution Yield  

as of 30-Jan-2015

0.72%
30 Day SEC Yield  

as of 30-Jan-2015

1.37%

This information must be preceded or accompanied by a current prospectus. For standardized performance, please click on the "Returns" tab above.

More Products

No recently viewed funds available

Carefully consider the Funds' investment objectives, risk factors, and charges and expenses before investing. This and other information can be found in the Funds' prospectuses or, if available, the summary prospectuses which may be obtained by visiting the iShares ETF and BlackRock Mutual Fund prospectus pages. Read the prospectus carefully before investing.

Investing involves risk, including possible loss of principal.

International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial volatility due to adverse political, economic or other developments. These risks often are heightened for investments in emerging/developing markets or in concentrations of single countries.

Funds that concentrate investments in specific industries, sectors, markets or asset classes may underperform or be more volatile than other industries, sectors, markets or asset classes and than the general securities market.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Market returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. eastern time (when NAV is normally determined for most ETFs), and do not represent the returns you would receive if you traded shares at other times.

Index returns are for illustrative purposes only. Index performance returns do not reflect any management fees, transaction costs or expenses. Indexes are unmanaged and one cannot invest directly in an index. Past performance does not guarantee future results.

After-tax returns are calculated using the historical highest individual federal marginal income tax rates and do not reflect the impact of state and local taxes. Actual after-tax returns depend on the investor's tax situation and may differ from those shown. The after-tax returns shown are not relevant to investors who hold their fund shares through tax-deferred arrangements such as 401(k) plans or individual retirement accounts.

Certain sectors and markets perform exceptionally well based on current market conditions and iShares Funds can benefit from that performance. Achieving such exceptional returns involves the risk of volatility and investors should not expect that such results will be repeated.

The Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”).

The iShares Funds are not sponsored, endorsed, issued, sold or promoted by Cohen & Steers Capital Management, Inc., European Public Real Estate Association ("EPRA®"), FTSE International Limited ("FTSE"), India Index Services & Products Limited, JPMorgan Chase & Co., MSCI Inc., Markit Indices Limited, Morningstar, Inc., The NASDAQ OMX Group, Inc., National Association of Real Estate Investment Trusts (“NAREIT”), New York Stock Exchange, Inc., Russell Investment Group or S&P Dow Jones Indices LLC, nor are they sponsored, endorsed or issued by Barclays Capital Inc. None of these companies make any representation regarding the advisability of investing in the Funds. BlackRock is not affiliated with the companies listed above. Index data related to the underlying indexes is provided by the respective companies above.

Neither FTSE nor NAREIT makes any warranty regarding the FTSE NAREIT Real Estate 50 Index, FTSE NAREIT Residential Plus Capped Index, FTSE NAREIT Industrial/Office Capped Index or FTSE NAREIT All Mortgage Capped Index; all rights vest in NAREIT. Neither FTSE nor NAREIT makes any warranty regarding the FTSE EPRA/NAREIT Developed Real Estate ex-U.S. Index, FTSE EPRA/NAREIT Developed Europe Index, FTSE EPRA/NAREIT Global REIT Index or FTSE EPRA/NAREIT Developed Asia Index; all rights vest in FTSE, NAREIT and EPRA. "FTSE®" is a trademark of London Stock Exchange Group companies and is used by FTSE under license.

©2015 BlackRock, Inc. All rights reserved. BLACKROCK, BLACKROCK SOLUTIONS, BUILD ON BLACKROCK, ALADDIN, iSHARES, iBONDS, iTHINKING, iSHARES CONNECT, FUND FRENZY, LIFEPATH, SO WHAT DO I DO WITH MY MONEY, INVESTING FOR A NEW WORLD, BUILT FOR THESE TIMES, CoRI and the CoRI logo are registered and unregistered trademarks of BlackRock, Inc., or its subsidiaries in the United States and elsewhere. All other marks are the property of their respective owners.

iS-11932